Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.
about
Distribution of fitness effects among beneficial mutations before selection in experimental populations of bacteriaEfflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatisgyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae.Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections.Broader distribution of plasmid-mediated quinolone resistance in the United StatesImpact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli.Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures.Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure.Dynamics of quinolone resistance in fecal Escherichia coli of finishing pigs after ciprofloxacin administration.Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infectionsSalmonella typhimurium gyrA mutations associated with fluoroquinolone resistance.Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers.Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.The population dynamics of antimicrobial chemotherapy.Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.Mechanisms of resistance to quinolones.In vitro evaluation of the potential for resistance development to ceragenin CSA-13.Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistanceDevelopment of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.Clinical implications of reduced susceptibility to fluoroquinolones in paediatric Shigella sonnei and Shigella flexneri infectionsThe use of platensimycin and platencin to fight antibiotic resistance.Development and validation of a diagnostic DNA microarray to detect quinolone-resistant Escherichia coli among clinical isolates.Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.Collateral sensitivity of antibiotic-resistant microbes.Prediction of antibiotic resistance: time for a new preclinical paradigm?Evolution of Drug Resistance in Bacteria.Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coliDetection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones.Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus.DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa.Enhanced resistance to fluoroquinolones in laboratory-grown mutants & clinical isolates of Shigella due to synergism between efflux pump expression & mutations in quinolone resistance determining region.Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli.Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance.Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli.Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.Pharmacodynamic modeling of in vitro activity of marbofloxacin against Escherichia coli strains.Novel combination of mutations in the DNA gyrase and topoisomerase IV genes in laboratory-grown fluoroquinolone-resistant Shigella flexneri mutants.
P2860
Q22122042-DB84D972-DE64-4CEB-B4CC-19F381BE54FBQ28378761-DC863A2C-FF20-40DC-925A-121053DEA754Q33699643-AD888D33-9ADC-4D96-9E11-682E2FF48C52Q33836664-36004F19-FC8C-40B0-B0C3-64BF6F2DA457Q33883639-B4517087-15D5-4DAE-BD00-63D929FB4207Q33976675-45656039-BAFC-4205-95EA-7211C1130754Q33979064-89F3EF2D-ED50-4556-B2E5-9B1D659DBE78Q33982113-1C808B3B-FF45-47EC-95BD-2C3EF785C13BQ33983331-0DA94112-84CD-463B-8025-CF10D5B504DEQ34019104-74C46BCE-53C7-48C3-AC10-49D092EED7DEQ34339497-FAF641FB-1A53-4F9E-8DC3-41051B361707Q35111896-54C955BE-F70C-4DCF-AFA4-B66651990EFEQ35116590-990E5DA5-2620-43DC-8B53-EBD5D0F06F33Q35122412-37D4D34E-A5F0-4FE3-BC89-E36449FE8D76Q35123629-03E433F9-1817-4BEB-95D0-B24CA66A95C3Q35131092-585BF1A3-6877-47E7-B1B8-ABC9CA3EA9E0Q35132378-040FC682-D330-4CC6-A8A8-BC86D19BF4E0Q36048167-0B4B1DFE-ED34-40B9-8D37-0C1F59DCDDAEQ36155441-1C5AE557-8365-4693-9D58-B0FCDD450128Q36308072-73606A4C-3849-48E3-84AC-383A1044663DQ36528206-96CE3861-47C4-4016-8FDB-35675358695DQ36546371-40710460-E635-46D7-813D-C4916AA805A8Q36551331-E3DFAB9E-125F-4203-9C2A-2D220A492ED8Q37203095-BE74EFC4-30E7-4B79-ABBF-681C324A4FDDQ37511160-3B60C535-967C-4BF8-985A-5F83D964089DQ37612974-263E1656-62BB-49DB-93AE-AAF07415DE2BQ38394500-830025CF-353E-4947-B429-DCBE878FA92DQ38649580-0B214128-8E82-4203-8D2E-8757BEE1A989Q38837707-DBAC32F0-A0A2-479A-8087-0476CA15F84BQ39020968-2A79CF25-F636-439F-A917-E9A8C3F2D517Q39469894-9B2AFFFA-9E49-4A3A-82B8-E79BB77B636EQ39780047-BEFF0E03-296B-4EDA-9904-59445CFA6326Q39780359-8EE8999C-4EEC-4F63-82F8-2AD6D32FD70FQ39860153-0B53E1B6-6815-4278-9FD8-A896BD373124Q40874282-5963A531-F241-4A04-B564-3C56BF616CB1Q41454301-A5D16DC4-321D-4C63-8236-18364357E24DQ41788804-532FFC72-03C7-45AC-B153-D7C83739527CQ41810482-D4DF6728-C480-4E4D-9C80-0C25AD719529Q42583041-8E109301-0785-43C2-BF9F-6DCECFD38478Q42743898-443330E9-DB26-42C8-8D15-258219F84367
P2860
Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Characterization of fluoroquin ...... richia coli selected in vitro.
@ast
Characterization of fluoroquin ...... richia coli selected in vitro.
@en
type
label
Characterization of fluoroquin ...... richia coli selected in vitro.
@ast
Characterization of fluoroquin ...... richia coli selected in vitro.
@en
prefLabel
Characterization of fluoroquin ...... richia coli selected in vitro.
@ast
Characterization of fluoroquin ...... richia coli selected in vitro.
@en
P2860
P356
P1476
Characterization of fluoroquin ...... richia coli selected in vitro.
@en
P2093
P2860
P304
P356
10.1128/AAC.38.6.1284
P407
P577
1994-06-01T00:00:00Z